Metraipolis › archive › dc_a61427cbbf15
PIK3CA mutations in HER2-positive Breast Cancer Patients; Frequency and Clinicopathological Perspective in Egyptian Patients — Europe PMC PMID:28240010
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/28240010
- DOI
- 10.22034/apjcp.2017.18.1.57
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-09T22:19:10.292Z
- SHA-256 of the archived text
1fd566cc14b938368299542f16c4c9418609e2aa5a07c0863d07c42833a59853- Stable URL of this page
https://metraipolis.com/documento/dc_a61427cbbf15
How to cite
PIK3CA mutations in HER2-positive Breast Cancer Patients; Frequency and Clinicopathological Perspective in Egyptian Patients — Europe PMC PMID:28240010 — Europe PMC (en), https://europepmc.org/article/MED/28240010 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_a61427cbbf15 (Metraipolis archive dc_a61427cbbf15, sha256 1fd566cc14b938368299542f16c4c9418609e2aa5a07c0863d07c42833a59853)
BibTeX
@misc{dca61427cbbf15,
title = {PIK3CA mutations in HER2-positive Breast Cancer Patients; Frequency and Clinicopathological Perspective in Egyptian Patients — Europe PMC PMID:28240010},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/28240010},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_a61427cbbf15; sha256 1fd566cc14b938368299542f16c4c9418609e2aa5a07c0863d07c42833a59853},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/28240010. Agents can read the archived copy with the MCP tool read_document.